ENTA(Enanta Pharmaceuticals, Inc.) · 内部人交易

ENTA(Enanta Pharmaceuticals, Inc.) 的内部人交易:医疗保健,生物技术。数据来自 SEC 公开申报与市场行情,不构成投资建议。

ENTA 最近的内部人买卖(Form 4)
交易日姓名职务类型股数价格
2025-12-05Capps Kathleen S.See Remarks公开市场卖出323$14.23
2025-12-05Trout Harry R. IIISee Remarks公开市场卖出542$14.23
2025-12-05Rottinghaus Scott T.Chief Medical Officer公开市场卖出798$14.23
2025-12-05Luu BrendanChief Business Officer公开市场卖出1,394$14.23
2025-12-05Kieffer Tara LynnChief Product Strategy Officer公开市场卖出2,106$14.23
2025-12-05Or Yat SunChief Scientific Officer公开市场卖出2,390$14.23
2025-12-05Luly Jay R.President and CEO公开市场卖出4,743$14.23
2025-12-02Capps Kathleen S.See Remarks公开市场卖出207$13.96
2025-12-02Trout Harry R. IIISee Remarks公开市场卖出380$13.96
2025-02-12Luly Jay R.President and CEO公开市场买入45,000$5.69
2024-12-06Kieffer Tara LynnChief Product Strategy Officer公开市场卖出2,283$8.06
2024-12-06Luu BrendanChief Business Officer公开市场卖出2,283$8.06
2024-12-06Rottinghaus Scott T.Chief Medical Officer公开市场卖出866$8.06
2024-12-06Or Yat SunChief Scientific Officer公开市场卖出2,591$8.06
2024-12-06MELLETT PAUL JChief Fin. & Admin Officer公开市场卖出2,591$8.06
2024-12-06Luly Jay R.President and CEO公开市场卖出5,142$8.06

Enanta Pharmaceuticals, Inc. ENTA